These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12147029)

  • 1. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
    Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
    Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.
    Heddle NM; Blajchman MA; Meyer RM; Lipton JH; Walker IR; Sher GD; Constantini LA; Patterson B; Roberts RS; Thorpe KE; Levine MN
    Transfusion; 2002 May; 42(5):556-66. PubMed ID: 12084163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.
    Heddle NM; Klama L; Meyer R; Walker I; Boshkov L; Roberts R; Chambers S; Podlosky L; O'Hoski P; Levine M
    Transfusion; 1999 Mar; 39(3):231-8. PubMed ID: 10204584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
    Yazer MH; Podlosky L; Clarke G; Nahirniak SM
    Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
    Klüter H; Bubel S; Kirchner H; Wilhelm D
    Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of adverse reaction rates for PAS C versus plasma platelet units.
    Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA
    Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
    Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
    Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
    Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
    Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing.
    Ferrer F; Rivera J; Corral J; Gonzalez-Conejero R; Lozano ML; Vicente V
    Transfusion; 2000 Jul; 40(7):781-8. PubMed ID: 10924604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
    Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplant.
    Sweeney JD; Kouttab NM; Penn CL; McHugh KE; Nelson EJ; Oblon DJ
    Transfusion; 2000 Jul; 40(7):794-800. PubMed ID: 10924606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the duration of platelet storage and the development of transfusion reactions.
    Sarkodee-Adoo CB; Kendall JM; Sridhara R; Lee EJ; Schiffer CA
    Transfusion; 1998 Mar; 38(3):229-35. PubMed ID: 9563401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions.
    Patterson BJ; Freedman J; Blanchette V; Sher G; Pinkerton P; Hannach B; Meharchand J; Lau W; Boyce N; Pinchefsky E; Tasev T; Pinchefsky J; Poon S; Shulman L; MacK P; Thomas K; Blanchette N; Greenspan D; Panzarella T
    Transfus Med; 2000 Sep; 10(3):199-206. PubMed ID: 10972914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions to platelet transfusion: the effect of the storage time of the concentrate.
    Muylle L; Wouters E; De Bock R; Peetermans ME
    Transfus Med; 1992 Dec; 2(4):289-93. PubMed ID: 1339583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.